Studies have shown that non-dioxin-like PCBs (NDL-PCBs) may act as ligands for PXR, thereby activating it and promoting hepatic gluconeogenesis, ultimately leading to insulin resistance [46]. The gene discussed is NR1I2; the disease is Insulin resistance.